|
Stroke |
Atherosclerosis
-CIMT is Used as a Tool for Atherosclerosis-Related Event Prediction and for the Evaluating Atherosclerosis Progression/Regression by Dr. Amjad AlMahameed
Pathophysiology & Epidemiology
-Of Strokes Source: Merck Inc.
VTE and Stroke
-A Deadly Combination by Dr. Amjad AlMahameed
Who Are We? Slide
Downloading Policy
Financial Disclosure
We Do Not
Promote Off Label Product Use
Copyright
Source of Slides
Editorial Policy
Links Policy
Privacy
Policy
Access
CME Programs
© 1999-2009 by
Clinical Trial Results .org. None of the materials on this website may be
reproduced, modified, distributed, transmitted, republished, displayed, or
performed unless prior written approval is obtained by Clinical Trial Results.
All such requests should be forwarded to Susan J. Marble at
smarble@clinicaltrialresults.org. For further information please see the
Policy section.
Webmaster